Connect Biopharma secures $20.2 million private placement

Connect Biopharma has successfully closed a private placement financing round, raising $20.2 million from new and existing investors. This funding infusion is strategically important as it extends the company's anticipated cash runway into the second half of 2027. The capital will likely support ongoing clinical development programs and operational activities. Securing this financing demonstrates investor confidence in Connect Biopharma's pipeline and future prospects, providing crucial resources to advance its therapeutic candidates through key milestones.